Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franck Morschhauser

Showing results (11-20 of 315) with videos related to

Pageof 32
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2015
Mechanisms of Action of Lenalidomide in B-Cell Non-Hodgkin LymphomaJohn G Gribben, Nathan Fowler, Franck Morschhauser
The New England Journal of Medicine|June 27, 2003
Neutropenia in patients treated with rituximabEric Voog, Franck Morschhauser, Philippe Solal-Céligny
Leukemia & Lymphoma|March 11, 2010
Veltuzumab (humanized anti-CD20 monoclonal antibody): characterization, current clinical results, and future prospectsDavid M Goldenberg, Franck Morschhauser, William A Wegener
Bulletin Du Cancer|October 30, 2007
[Management of anaemia in patient with cancer: results of the F-ACT study (French Anaemia Cancer Treatment)]Emmanuel Guardiola, Franck Morschhauser, Jean-Jacques Zambrowski, et al.
Leukemia & Lymphoma|September 7, 2010
Diversity in antibody-based approaches to non-Hodgkin lymphomaDavid Maloney, Franck Morschhauser, Ola Linden, et al.
Bulletin Du Cancer|July 9, 2013
[Brentuximab vedotin: new treatment for CD30+ lymphomas]Louis Terriou, Sarah Bonnet, Houria Debarri, et al.
The Oncologist|October 13, 2009
Rationale for consolidation to improve progression-free survival in patients with non-Hodgkin's lymphoma: a review of the evidenceFranck Morschhauser, Martin Dreyling, Ama Rohatiner, et al.
Bulletin Du Cancer|June 17, 2006
[Indications of G-CSF administration in hematologic disorders]Pauline Lionne-Huyghe, Frédérique Kuhnowski, Valérie Coiteux, et al.
Reproductive Biomedicine Online|February 2, 2010
Anti-Müllerian hormone follow-up in young women treated by chemotherapy for lymphoma: preliminary resultsChristine Decanter, Franck Morschhauser, Pascal Pigny, et al.
Leukemia & Lymphoma|April 25, 2007
Phase I/II trial of a P-glycoprotein inhibitor, Zosuquidar.3HCl trihydrochloride (LY335979), given orally in combination with the CHOP regimen in patients with non-Hodgkin's lymphomaFranck Morschhauser, Pier Luigi Zinzani, Michael Burgess, et al.
Pageof 32

Showing results (11-20 of 315) with videos related to

Sort By:
Pageof 32
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2015
Mechanisms of Action of Lenalidomide in B-Cell Non-Hodgkin LymphomaJohn G Gribben, Nathan Fowler, Franck Morschhauser
The New England Journal of Medicine|June 27, 2003
Neutropenia in patients treated with rituximabEric Voog, Franck Morschhauser, Philippe Solal-Céligny
Leukemia & Lymphoma|March 11, 2010
Veltuzumab (humanized anti-CD20 monoclonal antibody): characterization, current clinical results, and future prospectsDavid M Goldenberg, Franck Morschhauser, William A Wegener
Bulletin Du Cancer|October 30, 2007
[Management of anaemia in patient with cancer: results of the F-ACT study (French Anaemia Cancer Treatment)]Emmanuel Guardiola, Franck Morschhauser, Jean-Jacques Zambrowski, et al.
Leukemia & Lymphoma|September 7, 2010
Diversity in antibody-based approaches to non-Hodgkin lymphomaDavid Maloney, Franck Morschhauser, Ola Linden, et al.
Bulletin Du Cancer|July 9, 2013
[Brentuximab vedotin: new treatment for CD30+ lymphomas]Louis Terriou, Sarah Bonnet, Houria Debarri, et al.
The Oncologist|October 13, 2009
Rationale for consolidation to improve progression-free survival in patients with non-Hodgkin's lymphoma: a review of the evidenceFranck Morschhauser, Martin Dreyling, Ama Rohatiner, et al.
Bulletin Du Cancer|June 17, 2006
[Indications of G-CSF administration in hematologic disorders]Pauline Lionne-Huyghe, Frédérique Kuhnowski, Valérie Coiteux, et al.
Reproductive Biomedicine Online|February 2, 2010
Anti-Müllerian hormone follow-up in young women treated by chemotherapy for lymphoma: preliminary resultsChristine Decanter, Franck Morschhauser, Pascal Pigny, et al.
Leukemia & Lymphoma|April 25, 2007
Phase I/II trial of a P-glycoprotein inhibitor, Zosuquidar.3HCl trihydrochloride (LY335979), given orally in combination with the CHOP regimen in patients with non-Hodgkin's lymphomaFranck Morschhauser, Pier Luigi Zinzani, Michael Burgess, et al.
Pageof 32